Medicare Will Cover New Class of Alzheimer’s Drugs if Fully Approved by FDA, With Limits
FRIDAY, June 2, 2023 (HealthDay News) — Medicare will soon cover a new class of Alzheimer’s drugs if they receive full approval from the U.S. Food and Drug Administration, with some key limits. Along with being full approved, drug makers will also have to gather and keep data in aContinue Reading